National Bank of Canada
EPRX

National Bank of Canada’s Eupraxia Pharmaceuticals EPRX Stock Holding History

National Bank of Canada’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$3.91K Sell
730
-34
-4% -$182 ﹤0.01% 2175
2025
Q1 		$2.49K Buy
764
+721
+1,677% +$2.35K ﹤0.01% 2151
2024
Q4 		$135 Sell
43
-107
-71% -$336 ﹤0.01% 2397
2024
Q3 		$394 Buy
+150
New +$394 ﹤0.01% 2306